The risk of biological warfare and terrorism, including the introduction of harmful or deadly bacteria into the environment or the food chain, continues to grow as a primary concern of world governments.

OmniLytics’ technology is not only effective against such acts, it’s naturally safe and has no adverse effect on humans, animals, or the environment, and has absolutely no threat of the long-term buildup of hazardous residues. As a result of our experience, we are actively building a premier research organization focused on virology, bacteriology, and infectious disease control.

Our goal is to provide solutions for the immediate control and eradication of these types of risk without creating more damage by increasing the risk of long-term bacterial mutation or distributing toxic residues.

Remedies for preventative and emergency treatment of biological threats include the sanitation and decontamination of infected sites. Several research opportunities exist with respect to anthrax and other pathogenic bacterial strains that are of high interest and relevance.

Although this market is extremely vertical and application-specific, this opportunity could quickly consume the company’s entire pool of resources if the need arises. As a result of our research and testing, we are confident we have the capability to effectively neutralize anthrax and other bacteria-based biological weapons and threats.

With this in mind, OmniLytics is researching the development of products for the Department of Defense for extremely dangerous pathogens that may be used as weapons.